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SECTION I: INTRODUCTION 
A. NORMAL VENOUS STRUCTURE 
Before proceeding to explore selected aspects of venous pathology 
in the setting of venous hypertension, it is appropriate to review 
the normal microscopic architecture of veins. Excellent summaries of 
venous histology (Rhodin, 1974; Ham, 1974; Bloom and Fawcett, 1975) 
as well as more extensive treatises (Franklin, 1937) have been 
published. 
Arteries were first distinguished from veins by Praxagoras of 
Cos in the Fourth Century B.C. By the Third Century B.C., the fact 
that arteries tend to pulsate, while veins do not, had been appreciated. 
Aristotle was of the opinion that blood was contained only in the 
veins, the liver, and the right side of the heart, the arteries serving 
solely as the conduit for the "vital spirit," which was derived from 
transformed air in the lungs. By the Second Century, Galen propounded 
the view, held for the next fifteen hundred years, that the veins 
originate from the liver and communicate with the arterial system by 
means of minute terminal anastamoses, as well as foramina putatively 
located in the interventricular septum. 
The multilayered nature of the venous wall was also first alluded 
to by Galen, who felt that veins usually have one coat, except in 
areas necessitating firm external support, where an additional, external 
coat might be present. A clearer distinction between media (along 
with the unsuspected intima) and adventitia emerges from the work of 
Vesalius. He distinguished between an "essential" layer, containing 
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muscle fibers distinct from those found in skeletal muscle, and a 
looser, outer layer which he thought was derived from surrounding 
structures and which became progressively attenuated as veins pene¬ 
trated parenchymal organs. 
Charles Estienne first observed the venous valves in the mid 
Sixteenth Century. His work and that of other workers later in that 
century, particularly the studies of Fabricius ab Aquapendente, greatly 
influenced Harvey in finally establishing the directionality of blood 
flow and the nature of the circulation. It was the understanding of 
the blood's circulation that established and, indeed, defined the 
veins as directional units coursing at all times in the direction of 
the heart. Over the ensuing centuries, our understanding of the veins 
has become increasingly refined, with the venous system emerging not 
only as a passive conduit, but as an active participant in the complex 
web of neurohumoral integrative mechanisms which underlies the car¬ 
diac output. The postcapillary venule, the venous system’s smallest 
component, has taken on increasing importance as the key functional 
unit of the inflammatory response. 
Unlike the arterial system, strict correspondence between venous 
ultrastructure and caliber tends not to prevail. In his classic 
Monograph on Veins, Franklin (1937) felt that full justice could be 
done to the named veins only by means of exhaustive individual descrip¬ 
tions. Certain generalizations are possible, however. 
The vein wall, like that of the arteries, has three layers — 
tunica intima, tunica media, and tunica adventitia. These layers 
are not as distinct in veins as they are in arteries. This is partly 
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due to the paucity of elastic fibers in veins which prevents, in 
most instances, a clear demarcation of the layers by means of well- 
organized internal and external elastic membranes. In general, veins 
possess less smooth muscle and more collagen than arteries (Ludbrook, 
1966) . 
The tunica intima consists of a thin layer of continuous endo¬ 
thelium resting on variable quantities of connective tissue. The 
subendothelial connective tissue tends to be only moderately developed, 
even in large veins. The normal human portal vein has been found to 
be actually devoid of a subendothelium (Li, 1940; Wilson, 1961), while 
an age related increase in the thickness of the subendothelium has 
been noted in the human inferior vena cava (Stuart and Magarey, 1960) 
and saphenous vein (Lawrie et al., 1976). Increases in intimal 
thickness is one of the principal features of venous pathology. This 
has taken a considerable amount of time to be appreciated. Wagner 
and Herbut (1949) illustrate the normal structure of the saphenous 
vein with a photomicrograph showing marked intimal proliferation. 
A more refined understanding of intimal structure has come from 
the application of freeze-fracture methods (Simionescu et al., 1975 
and 1976). Using veins from rat omentum and mesentery, the intima 
of pericytic venules (20 ym to 50 ym in diameter) was seen to be inter¬ 
connected by a scattered array of complexes interpreted to be tight 
junctions. Gap junctions are first seen in association with tight 
junctions in muscular venules (50 ym to 200 ym in diameter). Similar 
but less discontinuous junctions are seen in the larger veins, inter¬ 
spersed with long, continuous tight junctions. These elements are 
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similar, but less elaborate than those present in arteries. 
The emergence of the tunica media as a distinct component of the 
vein wall was traced in subdermal vessels of rabbit skin by Rhodin 
(1969). Fibroblasts and pericytes (the latter are generally felt to 
be similar to fibroblasts, but have a more granular rough endoplasmic 
reticulum and, unlike fibroblasts, possess a basement membrane — 
these cells may be primitive smooth muscle cell precursors) first 
appear in post-capillary (pericytic) venules, and are present in in¬ 
creasing numbers with increases in vessel diameter. Collecting venules 
have one complete layer of pericytes external to the tunica intima, 
with an outer layer of cells described as fibroblasts. Occasional 
primitive smooth muscle cells (SMCs) are seen in muscular venules and, 
at the level of small collecting veins, a prominent media is seen, 
with several continuous SMC layers. Throughout this progression, the 
ratio of luminal diameter to wall thickness actually increases, from 
10 to 1 in post-capillary venules to 100 to 1 in small collecting 
veins. 
As veins increase in caliber, variations in the structure of the 
media become more apparent. In human kidney and spleen, venules 
larger than 300 pm in diameter may still have discontinuous SMC layers 
in the media. In large veins, particularly the inferior vena cava, 
the media may be so inconspicuous that longitudinally oriented adventi¬ 
tial SMC bundles may appear to be abutting directly on the intima. 
The veins of the maternal placenta, nail bed, retina, bond, brain, and 
meninges are generally devoid of SMC fibers, while the veins of the 
pregnant uterus, umbilical cord, and adrenal glands are richly supplied 
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with them (Payan and Gilbert, 1972). 
In general, the media of veins which receive substantial external 
support, e.g., those which are intramuscular and intraabdominal, have 
a thinner, less muscular media than those which do not. The veins 
of the lower extremity have significantly more smooth muscle than 
upper extremity veins. The arrangement of the SMCs also varies with 
location, with venous medial SMCs disposed primarily longitudinally 
in the thorax and abdomen, and circularly in the extremities. Longi¬ 
tudinally oriented fibers prevent the collapse of vessels of low 
internal pressure (Gross and Handler, 1939), while circular fibers 
facilitate the capacitance and pumping functions of the veins of the 
extremities. 
An interesting variation of venous medial structure is seen in 
the mammalian portal vein (Ts’ao, Glagov and Kelsey, 1971). The 
media of the extrahepatic segment of this vein consists of two mutu¬ 
ally perpendicular layers of SMCs, separated by an acellular fibrous 
layer. The inner zone is avascular, with circumferentially oriented 
SMCs. The outer zone is thicker, has longitudinally arranged SMCs, 
and is well vascularized. It is speculated that this arrangement may 
subserve a sphincteric role in mediating between the portal flow and 
hepatic vacular resistance. 
In the neurovascular complex entering the human kidney, a unique 
arrangement of medial smooth muscle has been demonstrated (Payan and 
Gilbert, 1972). Eccentric longitudinal muscle fibers were seen to 
extend from the vein wall to the parenchyma of the kidney, occasionally 
extending from one vein to another. Their function remains to be clarified. 

6 
The adventitia of veins is considerably thicker than the media. 
It consists of a network of loose connective tissue containing thick, 
longitudinally oriented bundles of collagen and elastin. Occasionally, 
longitudinally disposed SMCs may be present adjacent to the media. 
Circularly oriented cardiac muscle fibers are found in the adventitia 
of the pulmonary veins and venae cavae as they enter the heart. It 
is through the adventitia that the vessels which nourish the veins 
course. 
Sections treated with ortholidine or benzidine have been used to 
demarcate the course of the vasa venorum in dog and man (Brook, 1977) . 
Arterial (6.2 to 6.6 ym in diameter) and venous (9.0 to 133 ym) vasa 
were shown to be running together in groups of two and three. The 
venous vasa are more tortuous and have more branch points than arterial 
vasa. The caliber of both types of vasa becomes increasingly atten¬ 
uated as they course from adventitia into media. While vasa were seen 
adjacent to the intima in the human long saphenous vein, no direct 
communication with the vessel lumen was noted. It is suggested that 
a defect in the endothelium seen on scanning electron microscopy might 
constitute a capillary opening. 
It has been claimed (Bloom and Fawcett, 1975) that the inner 
aspects of vein walls are better vascularized than that of arteries. 
In general, the media of veins is better vascularized than arterial 
media, and is provided with a more elaborate lymphatic supply. This 
may partly account for the fact that tumor invasion occurs far more 
frequently in veins than in arteries. 
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In addition to the SMCs, the principal structural elements of 
the vein wall consist of networks of collagen and elastin. While 
present throughout the vein wall, the adventitia is particularly rich 
in collagen. In both media and adventitia in human veins, collagen 
bundles appear to be arranged longitudinally, and occasionally spirally. 
A unique double criss-cross network of collagen fibers has been 
demonstrated in the thoracic IVC of dog, rabbit and cat (Franklin, 
1931 and 1933), which is thought to explain the ability of these 
vessels to increase in length on inspiration by as much as 45 per cent. 
Spiral collagen fibers in human veins may subserve a similar role. 
Like the SMCs, the elastic fibers are, in general, oriented 
longitudinally in the veins of the thorax and abdomen, and circularly 
in the limbs. These relationships help explain the ability of the 
veins in the extremities to serve as capacitance vessels and conduits, 
as well as the ability to resist compression of the centrally situ¬ 
ated veins. 
Venous innervation is provided exclusively by alpha adrenergic 
post-ganglionic fibers (Koelle, 1975). Beta receptors and cholinergic 
fibers have not been identified. Afferent neural elements, including 
Pacinian corpuscles, have been demonstrated. 
Finally, the veins are unique in their possession of valves. 
The venous valves are essentially intimal folds arranged in the form 
of cusps whose free edges are oriented in the direction of blood flow. 
These cusps consist of little more than evaginations of endothelium 
resting on small amounts of connective tissue, particularly elastin, 
on the valve’s luminal side. In the region of valve sinuses, the vein 
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wall is very thin, being approximately 20 to 25 per cent the thickness 
of the rest of the vein wall in the newborn (Kampmeier and Birch, 
1927). The valves vary in number and location. They usually occur 
in pairs, but may be present singly. Most commonly, they are found 
at the mouth of, or immediately below, the entrance of major tribu¬ 
taries, and are increased in number as one progresses distally in the 




Phlebosclerosis may be found bearing numerous appellations in 
the literature, including venofibrosis, fibrous endophlebitis, hyper¬ 
plastic phlebitis and hypertrophy of the veins (Lev and Saphir, 1951). 
All these terms refer to a set of gross and microscopic alterations 
in vein walls similar in every way to its counterpart in the arterial 
system, arteriosclerosis. 
Veins displaying this process are truly "hardened," with variable 
degrees of endothelial, SMC and connective tissue proliferation, 
leading to fibrosis, with or without calcification. Atherosclerosis, 
on the other hand, is a more severely necrotizing process, and is 
marked by a greater degree of SMC degeneration and disruption of 
elastic fibers, more extensive fibrosis and neovascularization and, 
of course, the presence of intra and extracellular deposits of lipid 
(World Health Organization, 1958). Indeed, "sclerosis of vascular 
walls is seen in its purest and simplest form in the veins, where 
degenerative changes remain minimal and where, owing to the scanty 
development of these lesions, we are most likely to gain an under¬ 
standing of their origin" (Cramer, trans. by Geiringer, 1949). 
As will be discussed, atheromas do occur in veins, but are 
extremely rare in situations other than those involving surgical inter¬ 
position of veins as arterial conduits, and at the origin of the 
inferior vena cava. Phelbosclerosis is the characteristic response 
of the vein wall to venous hypertension. 
A more rigid definition of phlebosclerosis (Lev and Saphir, 1951) 
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restricts the use of the term to degenerative changes in the vein 
wall of a relatively cell-poor character, with more extensive fibrosis 
and elastic fiber disruption. Endophlebohypertrophy is taken to 
represent an earlier stage in phlebosclerosis, marked mainly by sub- 
endothelial, as well as medial, accumulations of SMCs, collagen and 
elastin. 
These changes appear to occur along a pathologic continuum, with 
venous changes of a degenerative nature being closely linked with 
abnormal rises in venous pressure. The distinction between endophlebo¬ 
hypertrophy and phlebosclerosis may also reflect the difference between 
physiologic adaptation and true pathology. It should be emphasized, 
however, that while sclerotic veins represent extremes of structural 
degeneration, they rarely appear in the literature as significant 
sources of morbidity and mortality. Venous varicosities in the lower 
extremity stand alone as common examples of phlebosclerosis associated 
with marked clinical symptomatology while thrombosis, as will be 
discussed in the section on venous bypass graft pathology, appears to 
actually constitute an early consequence of acute injury to veins. 
Lev and Saphir introduce the term senile phlebosclerosis to refer 
to degenerative changes in vein walls associated with advancing age, 
but unrelated to underlying endophlebohypertrophy. Decreases in SMCs 
and elastic tissue as a function of age have been described in the 
great saphenous vein (Neumann, cited by Li, 1940) but such changes 
have not been confirmed in the portal vein. 
While atherosclerosis may be generalized, phlebosclerosis tends 
to be segmental (Moschcowitz, 1960), usually appearing in areas where 
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the vein is exposed to mechanical or hydraulic stress. It has been 
argued (Hauswirth and Einsenberg, 1931) that the veins, by virtue of 
their greater delicacy and exposure to mechanical stress, should 
actually be more prone to sclerosis than arteries. In a study of 30 
veins taken from patients under the age of 40, it was concluded that 
phlebosclerosis is a disseminated process. Franklin (1937) is of the 
opinion that phlebosclerosis is a condition primarily associated with 
arteriosclerosis and systemic hypertension. Later work has not borne 
out these positions. 
Tedeschi (1941) observed gross adventitial thickening on the 
side of venous walls running parallel to arteries in the IVC, femoral 
and popliteal veins. While microscopic sections were not obtained, 
the side of the vein wall subjected to arterial pulsations appeared 
twice as thick as the opposite wall. 
Gross thickening of vein walls in conditions unrelated to venous 
hypertension has been observed primarily in the Cramer-Schilling 
lesion, a plaque of subendothelial fibromuscular and collagenous 
deposits located at the junction of the left iliac vein and IVC and 
extending some two centimeters proximally into the cava (Geiringer, 
1949) or at the confluence of the streams of the two iliac veins, 
along the posterior wall of the cava (Moschcowitz, 1960). This lesion 
has been noted in 50 per cent of post-mortem speciments, half of 
which contained fat, with or without calcifications (Schilling, as 
cited by Geiringer, 1949), and in all post-mortem specimens taken 
from patients over the age of 50 (Moschcowitz, 1960). Geiringer noted 
108 such lesions in 245 consecutive necropsies (44%). Eleven of the 
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plaques were studied microscopically, and five consisted exclusively 
of intimal hyperplasia, with a normal or atrophic media, and hyper¬ 
trophy of the adventitia. Five lesions stained positively for fat, 
although typical foam cells were not seen. No relationship was 
established between the presence of the Cramer-Schilling lesion and 
histories of venous congestion, hypercholesterolemia, and the presence 
of aortic atheromas. 
Similar lesions were found in 160 of 208 (77%) IVCs (Stuart and 
Magarey, 1960). Only 40 of the patients studied had histories of 
underlying venous congestion. Sixty per cent of these lesions con¬ 
tained fat, while 10 per cent were grossly, and 16 per cent micro¬ 
scopically calcified. These features were not related to age or sex, 
but were never seen in newborns. 
The confinement of these lesions to the origin of the IVC under¬ 
lines the importance of purely mechanical factors in the pathogenesis 
of phlebosclerosis and venous atheromas. Both Geiringer, and Stuart 
and Magarey point out that the Cramer-Schilling lesion arises in a 
region where the right common iliac artery courses over the orifice 
of the left common iliac vein, compressing this vein as well as the 
origin of the cava against the lumbar spine. One instance of a 
sinistriposed IVC has been reported by Geiringer, with the Cramer- 
Schilling lesion located near the orifice of the right common iliac 
vein. 
Proliferation of elastic, collagenous and SMC elements in the 
intima and intimal side of the media has been observed in 127 popliteal 
veins (Lev and Saphir, 1951) at the orifices of tributaries and in 
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regions adjacent to the popliteal artery. With advancing age, the 
lesions assumed an increasingly acellular character, with decreased 
numbers of SMCs and increased collagen in intima and media, as well 
as calcifications. Fat was not noted. This work suggests that 
sclerotic lesions in veins may arise even in the presence of minimal 
mechanical or hemodynamic stress. 
Phlebosclerosis has been noted in numerous clinical conditions, 
the common denominator of each being the presence, over variable 
periods of time, of elevations in venous pressure. These conditions 
include the great veins, pulmonary veins and portal veins in congestive 
heart failure (CHF), and the portal, splenic and mesenteric veins in 
portal hypertension. Similar changes are present in venous varico¬ 
sities. The more florid alterations seen in coronary artery bypass 
grafts form the subject of the next chapter. 
Gross and Handler (1939) examined the SVCs of 21 patients who 
had had histories of chronic congestive failure of various etiologies. 
Macroscopic changes consisting of slightly raised yellow plaques were 
found in two of the 21 vessels, but histological sections revealed 
slight intimal thickening in four, and marked thickening in 14. Ten 
of the 21 veins showed thickening, splitting and reduplication of 
elastic fibers. The intimal changes consisted primarily of increased 
quantities of collagen, with six of the veins containing SMCs in the 
subendothelium. Medial hypertrophy, consisting of SMC proliferation 
and collagen deposition, were noted in 17 of the vessels. The presence 
of fat or calcifications is not described. These changes could not be 
correlated with the duration or severity of clinical symptomatology. 

The authors describe the changes they observed as evidence of phlebo- 
sclerosis. Using Lev and Saphir's classification, the fact that 
elastic fiber fragmentation was found along with increased quantities 
of viable SMCs might place these changes somewhere between the extremes 
of endophlebohypertrophy and phlebosclerosis. 
Similar findings were obtained in a study of 208 post-mortem 
cases, 30 of which involved histories of CHF, and an additional 10 of 
which were marked by histories of portal hypertension (Stuart and 
Magarey, 1960). Apart from the Cramer-Schilling lesion, no macro¬ 
scopic plaques were seen in the 168 cases taken as controls. Of the 
30 cases with CHF, 29 had lesions in the great veins, characterized 
by subendothelial accumulations of fibrous connective tissue, elastin 
and SMCs. Four of the lesions stained positively for fat. In addi¬ 
tion, six of the 10 portal veins taken from patients with portal 
hypertension revealed similar changes. These histological alterations 
were found in regions displaying grossly visible, firm plaques, but 
even random sect ons showed thickening of the vein wall that was three 
to four times normal. In this study, duration and severity of venous 
congestion was seen to be related to the degree of observed pathology. 
A comprehensive survey of phlebosclerosis has been performed at 
Mount Sinai Medical Center, New York City (Moschcowitz 1959, 1960, 
1962, 1964; Moschcowitz and Strauss, 1964). This work suffers from 
containing a minimum of descriptive pathology, and the somewhat arbi¬ 
trary position that any degree of intimal thickening is tantamount 
to phlebosclerosis. That phlebosclerosis might properly be regarded 
as an end-stage which follows from the ultimate inability of 
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proliferative responses on the part of the vein wall to cope with 
abnormal transmural pressures is not considered. The initial response 
and the final outcome are not clearly distinguished. 
Nevertheless, Moschcowitz performed an important service by 
amassing a large body of data correlating structural changes in veins 
with clinical histories of venous congestion. In a pilot study of 
100 consecutive portal veins, intimal thickening was never noted 
except in the presence of presumed venous hypertension (Moschcowitz, 
1959). In 105 cases of CHF and intra and extrahepatic portal obstruc¬ 
tion, intimal thickening was a constant finding, although exact 
figures are not provided. No lipid or reduplication of the internal 
elastic membrane was noted. In 162 cases of CHF, intimal collagenous 
thickening was found in 157 IVCs (94.6%), excluding the Cramer-Schilling 
lesion (Moschcowitz, 1960). In the 49 IVCs displaying the most marked 
changes, the duration of symptomatology was found to be double that 
of the other cases studied. In addition, 26 of the 49 cases (53%) 
had histories of valvular heart disease, suggesting relatively pro¬ 
longed venous congestion. No relationship was established between 
the degree of intimal thickening and the presence of diabetes mellitus. 
Intimal thickening was demonstrated in 151 pulmonary veins, of 
which 146 (97%) were taken from cases of CHF (Moschcowitz, 1962). 
There were concordance rates of 96% and 40% between pulmonary vein 
pathology and intimal thickening in the IVC and portal vein, respec¬ 
tively. 
Further evidence for the cardinal importance of venous hyper¬ 
tension in the generation of adaptive and Regenerative changes in the 
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vein wall may be gleaned from the fact that structural alterations 
were never found in the coronary veins from 50 patients with CHF 
(Moschcowitz, 1964). The free anastamoses between these veins and 
the Thebesian vein, coupled with the usual incompetence of the Thebe¬ 
sian valve in the coronary sinus, apparently prevent the development 
of undue increases in pressure. 
The portal vein has been studied in 30 cases of cirrhosis of the 
liver (Wilson, 1961) and 26 cases of CHF, chronic airway disease and 
cirrhosis (Li, 1940). Controls taken from cases in which venous 
congestion was absent showed a complete lack of a subendothelial 
layer in two and 26 portal veins, respectively. Twenty nine of 31 
portal veins studied by Wilson (one additional portal vein was obtained 
from a case or recurrent hematemesis and splenomegaly without cirrhosis) 
showed varying degrees of thickening affecting all layers of the vein 
wall, with SMCs and collagen accumulating in the subendothelium, and 
SMC hypertrophy in the media and adventitia. Three of the most 
advanced lesions displayed organizing thrombi within the intima, raising 
the possibility that organization and incorporation of thrombi may 
be involved in the most florid examples of hypertensive venous path¬ 
ology. Li's findings are similar, with 20 of 26 cases (77%) showing 
proliferative lesions. Neither author found atheromas. 
Sclerosis of the wall of the portal vein has been reported in a 
21 year old female with Banti's Syndrome (Reich, 1942). All layers 
of the vein wall were affected, with SMC degeneration and replacement 
with hyalinized areas of connective tissue. Whiteley (1953) found a 
thrombosed portal vein in a 64 year old female with cirrhosis. An 

17 
area of marked fibrous intimal proliferation was seen proximal to the 
thrombus. This region was calcified, contained fibrin, and stained 
positively for fat. Risk factors for atherosclerosis are not noted. 
An unfortunate drawback of this type of work is that correlations 
with duration and degree of clinical symptomatology and alterations 
in venous structure tend to be largely impressionistic. Data derived 
from portal manometry and cardiac catheterization would have been of 
interest in these studies, but the bulk of classical histological 
investigations involving sclerotic veins were performed before these 
tools came into general use. One semi-quantitative approach was taken 
by Wilson (1961), who established a positive correlation between 
structural changes in the portal vein in portal hypertension and 
spleen weight. 
Venous varicosities are the most familiar examples of sclerosis 
in the venous system. The controversy regarding the primary or 
secondary role played by valvular incompetence in the generation of 
varicose veins has been reviewed by Ludbrook (1962). 
Nicholson (1927) found thickening of the intima in venous vari¬ 
cosities, with SMCs accumulating in the subendothelium. Moving dis- 
tally along affected veins, the amount of connective tissue was found 
to increase, accompanied by attenuation of elastic fibers. Stein, 
Rosenblum and Leather (1966) studied veins obtained from phlebectomies 
performed for varicosities. Intimal thickening was observed in the 
absence of subendothelial cellular proliferation. The intimal thicken¬ 
ing consisted primarily of an increase in eosinophilic ground substance. 
Medial fibrosis was noted, and was accompanied by secondary elastosis. 
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The distribution of ATPase, succinic dehydrogenase, NAD diaphorase, 
alkaline phosphatase, acid phosphatase, glucose-6-phosphatase and 
non-specific esterase was found to be identical with that of normal 
veins. Atherosclerotic plaques, on the other hand, are marked by 
increased phosphatase activity within the intima. Fat was not iden¬ 
tified. The histologic alterations which have been found in venous 
varicosities appear to constitute phlebosclerosis, strictly speaking. 
In addition, these findings suggest a possible pathogenetic role for 
stasis and anoxia, in addition to increases in pressure, in the 
development of these lesions. 
The question of the temporal primacy of medial versus intimal 
thickening has been debated. Areas of medial hypertrophy with a normal 
intima have been found in the mesenteric veins (Li) and portal vein 
(Wilson) of patients with portal hypertension. Furthermore, Li reports 
regional differences in vein wall hypertrophy, with adventitial 
hypertrophy actually exceeding medial hypertrophy in the IVC in CHF 
and chronic airway disease. This selectivity, which was not confirmed 
by Wilson, is explained by the fact that the IVC is fixed at both ends, 
so that hypertrophy of longitudinal adventitial SMCs suffices to 
decrease wall tension in the face of increases in transmural pressure. 
Partial ligation of the IVC of rabbits has been performed (Ts'ao 
and Spaet, 1967), with sections removed at fixed intervals for electron 
microscopy. The initial effect of increases in vein wall tension 
involved accumulation of mitochondria and lysosomes in endothelial 
cells, with dilatation of rough endoplasmic reticulum and prolifera¬ 
tion of Golgi elements. This was seen within minutes. Autolysis of 
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endothelial cells was seen after one hour. After two hours, leuko¬ 
cytes and SMCs were observed in the subendothelial space. Medial 
changes were less dramatic, with SMC necrosis noted on the intimal 
side of the media. 
More recent evidence derived from studies of the arterial system 
strongly suggests that myointimal thickening and medial hypertrophy 
unfold as an orchestrated process (Ross and Glomset, 1973; Fishman, 
Ryan and Kamovsky, 1975; Ross, Glomset and Harker, 1977). As Virchow 
stated in 1856, endothelial injury is the primary event in athero- 
genesis. Endothelial desquamation, with the concommitant release of 
platelet-borne mitogenic factors, appears to be of prime importance 
in the subendothelial accumulation of connective tissue and SMCs. 
In the absence of experimental evidence, one may speculate that a 
similar series of events occurs in injured veins. The role of the 
adventitia in this process is not clear, but adventitial SMCs may 
respond to similar factors, or they may be more dependant on the 
integrity of the vasa venorum. 
How undifferentiated SMC precursors migrate through the internal 
elastic membrane is not clear. Evidence regarding the probable 
medial origin of intimal SMCs in veins is presented by Geiringer (1949), 
while Haust, More and Hovat (1960) provide strong electron microscopic 
evidence for the SMC characteristics of cells embedded in the con¬ 
nective tissue matrix of human atheromas. 
The rapidity with which alterations of this nature develop may 
be gauged from reports of extreme intimal thickening in the portal 
vein of a 7 1/2 month old child with congenital biliary atresia 
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(Moschcowitz, 1959), and in the IVC of a 23 day old with multiple 
congenital cardiac anomalies (Moschcowitz and Strauss, 1964). 
An additional issue raised by several studies involves the time 
sequence of elastic fiber deposition and degeneration in these lesions. 
In a series of 50 patients with left sided CHF, intimal thickening 
marked primarily by the presence of fibrous and elastic tissue (inti¬ 
mal fibroelastosis) was found in the pulmonary veins of 21, with a 
total of 46 displaying some degree of intimal thickening (Hutchins 
and Ostrow, 1976). According to Lev and Saphir, the progression of 
phlebosclerosis is marked by successive decrements in elastic tissue. 
On the other hand, Wilson (1961) found the greatest degree of elastic 
tissue deposition in the most fibrotic portal veins of patients with 
cirrhosis, particularly those with organized thrombi. 
The opposite relationship has been found between the presence 
of organized thrombi and granulation tissue, and proliferation of 
elastic tissue in healed myocardial infarcts (Hutchins and Bannayan, 
1971). Subendocardial fibroelastosis was the presumed response to 
increases in myocardial wall tension following infarction, except in 
regions containing organized thrombi. Moschcowitz (1960) denies that 
thickening of the internal elastic lamina or proliferation of elastic 
tissue occurs in sclerotic veins, while elastosis was a constant 
feature of venous varicosities examined by Stein, Rosenblum and Leather 
(1966). 
Whether elastin is actually present in many of these lesions is 
an issue raised by Gillman et al. (1955), who studied "elastotically 
degenerated" arteries with a battery of fifteen histochemical stains. 
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Elastic fibers in these blood vessels were noted to be thicker and 
more granular than the elastin of the internal elastic membrane, 
and consistently failed to reproduce the membrane's staining proper¬ 
ties. It remains to be established whether intimal and subendocardial 
fibroelastosis represents an adaptive increase in elastic tissue, a 
degenerative alteration of pre-existent elastin or, possibly, an 
entirely different material. 
Of interest are alterations in vein walls which have not been 
directly linked to increases in venous pressure. Micronodular phlebo- 
sclerosis refers to focal accumulations of SMCs and connective tissue 
in vein walls which have been found to impinge on the lumens of 30% 
of renal and 51% of adrenal veins taken from 100 consecutive autopsies, 
averaging 62 years in age (Payan and Gilbert, 1968). Obliterative 
intimal fibrotic changes with medial sparing has been seen in primary 
pulmonary veno-occlusive disease (Carrington and Liebow, 1970; Heath, 
Scott and Lynch, 1971). The role of ionizing radiation, antineoplastic 
and immunosuppressive agents, arsphenamine, urethane and graft versus 
host disease in the pathogenesis of non-thrombotic proliferative 
lesions in the walls of centrilobular and sublobular hepatic veins 
has been reviewed by Berk et al. (1979). 
It thus appears that increases in venous pressure are of central, 
although not exclusive, importance in the pathogenesis of structural 
changes in vein walls. A variety of initial injuries may set into 
motion a set of stereotyped responses leading to intimal thickening. 
Persistence of injurious stimuli, possibly in association with the 
affects of advancing age, leads to the development of sclerosis. The 
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time period over which these changes arise are telescoped into weeks 
and months in autogenous vein grafts. 
/ 
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C. AUTOGENOUS VEIN GRAFTS: ANATOMIC PATHOLOGY 
The study of autogenous vein grafts (AVG) provides an opportunity 
for evaluating the contributions of a wide range of factors to the 
development of sclerotic and atheromatous changes in the vascular 
wall. Relative hypertension, stasis, turbulence, anoxia and hyper¬ 
lipidemia have all been implicated in the pathogenesis of thrombosis, 
fibrous intimal proliferation (FIP) and atherosclerosis — the principal 
pathologic alterations which have emerged from a large number of 
studies in experimental animals and man. 
In 1906, Jose Goyanes of Spain performed what is thought to be 
the first AVG in man when he utilized a segment of popliteal vein to 
replace a resected syphillitic aneurism in the popliteal artery of a 
41 year old man (Harrison, 1976). His achievement derived in part 
from the experimental work of Alexis Carrel who, with Morel at Lyons 
University and Guthrie at the University of Chicago, established the 
methodology of modem vascular surgery. In part for this work, Carrel 
received the 1912 Nobel Prize for Medicine or Physiology. 
The development of radiologic contrast methods to localize arter¬ 
ial obstructions and the use of heparin to control the problem of 
intraoperative thrombosis has facilitated the application, over the 
last two decades, of AVGs in the treatment of atherosclerotic coronary 
vascular disease (ASCVD), peripheral vascular disease and renal 
artery stenosis. 
Fifteen years ago, the first saphenous vein (SV) coronary artery 
bypass graft (CABG) was performed at the Methodist Hospital in Houston, 
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Texas. The case was not reported until 1973, five years after the 
technique for bypass grafting for ASCVD, culled from extensive experi¬ 
ence at the Cleveland Clinic, was published by Rene Favaloro (1968). 
It is beyond the scope of this discussion to review the large 
body of data which has accumulated since 1968 regarding the specific 
clinical indications for performing CABGs, and the correlations which 
have emerged between preoperative clinical and angiographic findings, 
and morbidity and mortality following medical or surgical therapy 
for ASCVD. Over 300,000 CABGs have been performed to date, of which 
over 1200 have been studied in a random, controlled manner. These 
controversial issues have been reviewed by McIntosh and Garcia (1978) 
and Hurst, King, Logue et al. (1978). 
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1. Morphologic Finding? 
Fibrous intimal proliferation has been a common finding in auto¬ 
genous vein grafts. This entity appears to duplicate the time and 
pressure related lesions which have previously been identified in situ 
in the venous system. The rate at which the lesions develop, however, 
appears to be accelerated in the presence of systemic blood pressure 
and pulsatile flow. 
A selection of investigations which have produced noteworthy 
examples of FIP in vein grafts is presented in Table 1. In general, 
early lesions tend to be relatively cellular, consisting primarily 
of SMCs in a loose matrix of collagen, elastic fibers (not a uniform 
finding), and acid mucopolysaccharides. With time, sclerosis super¬ 
venes and the intimal lesions assume a fibrotic, acellular character. 
Concommitant changes affect the media and adventitia. Interpretations 
of medial changes vary as to whether the media is spared in the short 
run, or actually displays some early degree of SMC hypertrophy before 
becoming fibrosed. Other controversial issues devolve around the 
rapidity with which FIP develops, the extent to which the process 
is progressive and stenosing, and, of course, the relative importance 
of individual pathogenic factors. 
Alterations in venous grafts clearly reflect an inherent capacity 
of the intact vein wall to respond to a wide range of possible insults. 
An experiment involving the grafting of a formalin-fixed segment of 
heterologous IVC onto the common carotid artery of a dog (Klotz, 
Permar and Guthrie, 1923) as the clinical use of Dacron grafts in 
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TABLE 1: FIBROUS INTIMAL PROLIFERATION IN AUTOGENOUS VEIN GRAFTS 
Author(s) Type of AVG Findings 
Grondin et al., 1971a CABG Two 114 day old grafts with 
marked FIP 
Marti et al., 1971 CABG 100% of grafts with FIP, (0 to 
10 months), including two from 




CABG 19 of 19 (100%) unchanged at up 
to 7 days, slight FIP in 2 of 2 
(100%) at less than 30 days, 
marked FIP in 6 of 8 (75%) at 
3.5 to 9 months 
Hamaker et al. , 1972 CABG One graft with marked FIP at 
15 weeks 
Kern et al., 1972 CABG Slight intimal edema and fibrosis 
in 7 of 7 at less than 30 days, 
marked FIP in 9 of 9 older than 
30 days 
Szilagyi et al., 1973 Femero- 
Popliteal 
SV graft 
4 of 21 (19%) with FIP at average 
of 11 months 
Barboriak et al., 
1976 
CABG 17 of 17 with FIP at 1 to 53.5 
months, with 7 of 17 (41%) occlud< 
entirely by FIP 




CABG 17 of 83 (21%) with FIP at less 
than 30 days, 14 of 14 with FIP 
at more than 30 days 
Roscher and Kern, 
1977 
CABG FIP seen in 3 of 26 post-mortem 
cases (0-21 months) 
CABG - coronary artery bypass graft 
FIP - fibrous intimal proliferation 
SV - saphenous vein 

27 
peripheral vascular surgery (DeBakey et al., 1964) have shown that 
essentially inviable conduits may become fully endothelialized and, 
in the case of one Dacron graft, may accumulate lipid beneath the 
neoendothelium. A markedly thick subendothelial layer has not been 
demonstrated in such grafts. A characteristic feature of FIP is that 
the ratio of intimal to medial thickness often exceeds three, and 
even four (grade 3 and 4 intimal proliferation). 
Some degree of intimal thickening may precede the transposition 
of SVs into the arterial system. Grade 1 and 2 intimal thickening 
was a uniform finding in 200 SVs taken from patients in the fifth 
and sixth decades of life (Lawrie et al., 1976). Florid FIP or 
atherosclerosis, however, has never been found in a SV prior to use 
as an AVG. 
Saphenous veins are prepared for use as a bypass graft by mecha¬ 
nical dilatation, usually with heparinized saline. This is done to avert 
spasm in the graft. Considering the likely importance of endothelial 
injury in the etiology of intimal thickening, as well as atherosclerosis, 
the effects of dilatation on the venous endothelium is of interest. 
Barboriak et al. (1976b) obtained three SVs which had been rou¬ 
tinely prepared for coronary artery grafting, and found that one 
displayed focal areas of endothelial denudation. Both scanning and 
transmission electron microscopy were used to confirm these findings. 
One of two grafts removed after 50 months in place had an intact 
endothelium, with the other having areas of endothelial loss — but 
with little adherent fibrin or platelets, suggesting that this finding 
was artifactual. Distension of canine cephalic veins at pressures 
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usually utilized in graft preparation (up to 600 mm Hg) has been seen 
to result in marked endothelial disruption, with increases in size, 
flattening and loss of microvilli in remaining endothelial cells, 
tearing of elastic fibers, partial detachment of the adventitia, and 
necrosis of medial SMCs (Ramos et al., 1976). 
Focal loss of endothelial cells has been noted in two thirds of 
CABGs examined within hours of transplantation (Unni et al., 1974). 
Autologous cephalic and femoral veins used in CABGs in dogs were seen 
to have patchy areas of endothelial loss after only 24 hours in place 
(Brody, Angell and Kosek, 1972). In addition, canine SVs which had 
not been dilated, but simply placed in saline for 90 minutes, displayed 
greater than 50% loss of endothelium using en-face silver preparations. 
This loss progressed to 70% after 48 hours as end to end femoral 
artery grafts, with complete endothelial restoration apparent only 
after 12 weeks (Wyatt and Taylor, 1966). 
Aside from endothelial loss, early CABG changes (those noted in 
grafts in place for less than seven days) have either been unappre- 
ciable (Vlodaver and Edwards, 1971) or, more frequently, have con¬ 
sisted of some degree of laminar fibrin deposition in the intima 
(Unni et al., 1974; Lie et al., 1977; Bulkley and Hutchins 1977 and 
1978). Dewangee et al. (1978) demonstrated significant early platelet 
compartmentalization in SV CABGs in dogs. Indium-111 labelled 
platelets were injected intravenously after surgery, and gamma scintil¬ 
lation images showed activity in the grafts at eight and 32 hours 
post-operatively that was four to 15-fold increased with respect to 




Early polymorphonuclear leukocytic (PMN) infiltration of the 
presumably injured graft wall has not been a uniform finding. Unni 
et al. (1974) note a modest degree of PMN infiltration in one CABG 
removed within hours of insertion, with more marked PMN infiltration 
and medial SMC necrosis seen in a second graft removed within 30 days 
of insertion. In general, PMN mediated injury has not been implicated 
as a major factor in CABG pathology. In experimental models, Stewart, 
Ritchie and Lynch (1974) implicate white blood cells in the propaga¬ 
tion of mechanical injury to canine jugular and femoral veins, while 
Malone and Morris (1978) suggest that white cells are more than simply 
passive participants in the induction of thrombosis in rabbit ear 
veins injured by hypoxia. 
Among the earliest changes which have been described in AVGs is 
a histochemical demonstration of increased ground substance (toluidine 
blue-positive material) and glucose-6-phosphate dehydrogenase activity 
in the intima of SV-femoral artery end-end grafts in dogs after 48 
hours (McCabe et al., 1967). This increase in G6PD activity may be 
related to an early rise in RNA and protein synthesis in grafted veins. 
SMC proliferation and acid mucopolysaccharide deposition may 
precede noteworthy deposition of collagen (Batayias, Barboriak et al., 
1977). While one light microscopic study was able to detect FIP in 
CABGs less than 12 days old (Marti, Bouchardy and Cox, 1971), most 
workers have concluded that FIP is not evident before 30 days (Vlodaver 
and Edwards, 1971; Unni et al., 1974; Barboriak et al., 1978). Intimal 
accumulation of SMCs has been seen at 19 days in an electron microscopic 
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study of a CABG (Unni et al., 1974). 
Increasing intimal fibrosis, marked by increased collagen depo¬ 
sition and SMC drop-out, appears in CABGs after about one year in 
place (Batayias, Barboriak et al., 1977). Many viable SMCs were still 
evident in a 21 month old densely fibrotic plaque (Kern, Dermer and 
Lindesmith, 1972). 
The inner and outer SMC layers of the media may show fibrotic 
changes within days post-operatively, with some initial SMC hyper¬ 
trophy occurring in the middle zone (Marti, Bouchardy and Cox, 1971). 
Older CABGs (weeks to months) have displayed medial SMC drop-out and 
increased fibrosis (Hamaker, O'Connel and Gomez, 1972; Kern, Dermer 
and Lindesmith, 1972). Similar findings have been noted in femero- 
popliteal SV grafts (Szilagyi et al., 1973). Batayias, Barboriak 
et al. (1977) found significant medial sclerosis only in CABGs one 
to three years old, with the media essentially unchanged before six 
months. Some workers (Vlodaver and Edwards, 1971; Unni et al., 1974) 
have been unable to find significant medial changes in CABGs three 
to nine months old. Considering the marked medial changes described 
in distended, pre-implantation grafts, some degree of structural 
restoration may occur in the media, as in the adventitia, before 
fibrosis ensues. 
While the exact nature and time course of medial changes remains 
to be pinpointed, it appears that grafted veins do not assume the 
histologic characteristics of arteries ("arterialization"). In addition, 
the extensive necrotic changes observed in arterioles in malignant 
hypertension (Crawford, 1977) do not occur. 
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Structural alterations in the adventitia have, in general, 
paralleled those observed in the media, with proliferative and ulti¬ 
mately degenerative changes a frequent finding. Bulkley and Hutchins 
(1977) have commented on the contribution made by pericardial adhe¬ 
sions to adventitial thickening in CABGs, and Marti, Bouchardy and 
Cox (1971) have seen increased elastin deposition in the adventitia 
of such grafts. The disruption of the adventitia as a result of 
mechanical dilatation is severe, with complete restoration evident 
only after three months in experimental animals (Ramos et al., 1976). 
The effects of transplantation into the arterial system on the 
vasa venorum vary. Mechanical dilatation, the care with which the 
surgeon preserves the adventitia (Ramos et al., 1976) and the solution 
used to dilate and temporarily store the veins (Abbot, Wieland and 
Austen, 1974) play important roles. Wyatt and co-workers (1964) found, 
using an India ink study, that two to six months are required for 
restoration of the architecture of the vasa in SVs used as femoral 
artery grafts in dogs. 
CABG patency rates have been high. Patency has been demonstrated 
angiographically in 80 to 90% of CABGs studied within a month of 
surgery (Bourassa et al., 1972; Walker et al., 1972; Lawrie et al., 
1976). Angipathologic correlations have been more difficult to estab¬ 
lish. This is primarily because peri-operative myocardial infarction 
(Langou, Wiles and Cohen, 1978) and problems arising from or exacer¬ 
bated by the surgical procedure itself, not graft closure, are the 
major causes of early death. 
In the relatively few closed grafts studied following death 
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within the first 30 post-operative days, thrombosis has been a major 
finding. Occluding thrombi have been seen in 3 of 14 (21%) of grafts 
one week to one month old (Unni et al., 1974). Bulkley and Hutchins 
(1977) found that patients dying intraoperatively had CABGs free of 
occluding thrombi, the incidence rising to 10% (2 of 21) at up to three 
weeks, and 43% (6 of 14) at one to 54 months. Organized thrombi have 
been reported in grafts in place for 8, 28 and 30 days (Kern, Dermer 
and Lindesmith, 1972), 34 days (Marti, Bouchardy and Cox, 1971) and 
in two of eight grafts examined at three to nine months (Voldaver 
and Edwards, 1971). 
Whether FIP progresses over time and becomes ultimately responsible 
for a significant proportion of graft failures is not entirely settled, 
but it appears that it does not. The angiographic correlate of FIP 
has been described as a diffuse, wavy narrowing of the graft wall 
(Szilagyi et al., 1973). Using angiographic data, Lawrie et al. (1976) 
contend that FIP becomes maximal at three months, and Barboriak et al. 
(1978) have found that intimal thickness in CABGs does not increase 
after six to nine months. Of 55 CABGs demonstrated to be patent at 
angiography one year after surgery, only three were occluded at three 
years (Lesperance et al., 1973). A non-critical decrease in caliber 
seen in 70% of grafts at one year did not progress thereafter. An 
additional indication of the tendency of FIP to become self-limited 
comes from evidence that progressive disability and death in patients 
with CABGs in place for longer than three to nine months is primarily 
due to progression of ASCVD in ungrafted vessels (Seides et al., 1978). 
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Several reports of graft closure entirely attributable to FIP 
suggest that the process is not a benign one, however. A few examples 
of this are listed in Table 1. The cases described displayed lumenal 
obliteration without superimposed thrombosis. An unresolved issue is 
the extent to which FIP affects a graft's predisposition towards 
thrombosis. Barboriak et al. (1976a) have found thrombi in older 
grafts displaying significant FIP. This has not occurred frequently, 
however, with the majority of thrombotic episodes appearing to take 
place in the immediate post-operative period. 
Typical atherosclerosis has been seen with increasing frequency 
in CABGs as long term survivors of coronary revascularization pro¬ 
cedures come to post-mortem examination. Atherosclerotic changes may 
develop with remarkable rapidity in autogenous vein grafts. For the 
most part, the observed changes conform with standard pathologic 
descriptions of atheromas. A summary of AVG atherosclerosis in both 
experimental and clinical settings, along with the presence or absence 
of appropriate risk factors for ASCVD, is presented in Table 2. 
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TABLE 2: ATHEROSCLEROSIS IN AUTOGENOUS VEIN GRAFTS 
Experimental 
Author (s) Model Findings 
Sako and Varco, 1962 Dog VC-AA graft 
(10 years) 
Extensive fibrosis (+) 
sudanophilic material 
in intima, (-) in adja¬ 
cent aorta 
Friedman, 1963 Rabbits JV-AA grafts 
(8 to 12 wks). Some 
thrombosed with Mg-Al 
spiral. (+) AS diet 
Grafts in hyper-C rab¬ 
bits : Typical AS Throm¬ 
bosed grafts: AS like 




(controls): no AS 
Penn et al., 1965 15 dogs JV or FV to 
CA or FA. Thyroid¬ 
ectomy + AS diet. 
Avg. 87 days 
Avg. C 443 
(+) FIP, lipid-laden 
SMCs in intima, (-) 
extracellular lipid 
Wyatt and Gonzalez, Dogs JV-CA grafts (9 
days-3 weeks) Thy¬ 
roidectomy, AS diet 
Avg. C 300-900 
Sudanophilic material, 
foam cells even in normo- 
C dogs; avg. C less than 
301: 80% patent, greater 
than 899: none patent 
King and Royle, 1972 Rabbits FV-FA grafts 
(10 days-4 months) 
AS diet 
100% AS Atheroma mainly 
on suture lines. More 
severe AS in rabbits put 
on AS diet before surger 




JV-AA (avg. 11 
months) 
JV-CA, JV-FA (avg. 
26 months) End-end 
and end-side grafts 
on opposite sides. 
Thyroidectomy, AS 
diet to avg. C of 
1000 
(+) AS 
Minimal AS in end-side 
grafts (o) AS in end- 




TABLE 2 (Cont'd) 
Author (s) Model Findings 
McCann et al. , 1975 Rhesus monkeys JV-IIA 
grafts (6 months) AS 
diet. Avg. C 648, 
avg. TG 189 
(+) FIP in all grafts, 
Hyper-C monkeys: lipid 
laden intimal SMCs seen 
on electron microscopy 
Clinical 
Author (s) Type of AVG/Risk 
Factors 
Findings 




Avg. C 283 
Marked AS in distal 
graft with proximal 
sparing (+) superimposed 
thrombosis in AS plaque 
Beebe, Clarke and 
DeWeese, 1970 
Fern-pop SV graft 
(57 months) 
Avg. C 735 
Intimal and medial 
fibrosis, (+) intimal 
lipid laden macrophages, 
cholesterol clefts 
Allard, Russito 
and Goulet, 1972 
CABG Angiographic 
Study 
TG 2 87 Graft closure at 2 weeks 
TG 244 Severe stenosis at 1 year 
TG 224 Wide patency at 1 year 
(Serum C not predictive) 
Barboriak, Pintar 




Hyper C or TG 
6 of 8 (+) AS 
6 of 6 (+) AS 
6 of 6 (+) AS 
Stehbens and 
Karmody, 1975 
Arteriovenous SV fis¬ 
tula for hemodialysis 
12 months, C 200-290 
(+) mild HTN 
(+) AS Lipid laden 
SMCs in loose intimal 
connective tissue matrix 
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TABLE 2 (Cont'd) 
Author(s) Type of AVG/Risk Findings 
Factors 
Farry, Hammond, 




C 202 TG 316 
(+) cigarette 
smoking 
(+) AS - clefts of necro¬ 
tic material surrounding 
cholesterol ester crystals 
(+) foam cells, calcifi¬ 
cation, hemosiderin laden 
macrophages 




C 295 TG 252 
(+) AS Large intra- 
intimal necrotic mass, 
lipid laden macrophages 
CABG 
20 months 
Type IV Hyper¬ 
lipoproteinemia 
(+) AS with lipid laden 
macrophages 
Batayias et al. , 
1977 
CABG 
older than 3 years 
3 of 6 (+) typical AS 
Lie, Lawrie and 
Morris, 1977 
CABG 
(-) DM, HTN 
59 grafts 
One year 




(+) AS in 11 of 14 (79%) 
from hyperlipidemic 
patients, and 3 of 26 
(11%) from normolipidemic 
patients 
Bulkley and Hutchins, 
1977 and 1978 
CABG 
Older than 30 days 
50% with lipid laden 
macrophages without other 
changes suggestive of 




TABLE 2 (Cont'd) 
Author(s) Type of AVG/Risk 
Factors 
Findings 




50% of grafts older 
than 3 years (+) 
typical AS 
Pintar et al., 1978 CABG 5 years 62 yo 
male, (+) h/o HTN, 
family h/o ASCVD, 
C & TG nl 
Both grafts displayed 
typical atheroscle¬ 
rotic aneurysms 
CAEG 6 years 
46 yo male 
C 228 TG 322-390 
Type IV pattern 
C - serum cholesterol in milligrams per deciliter, 
TG - serum triglycerides in milligram*per deciliter 
AA - abdominal aorta CA - carotid artery FA, FV - femoral artery, 
vein IIA - internal iliac artery JV - jugular vein VC - vena cava 




A great deal of evidence has been adduced implicating endothelial 
injury as a key trigger in the set of platelet-SMC interactions which 
lead to arterial intimal thickening (see references cited on page 19). 
The precise biochemical nature of this process, the roles played by 
membrane interactions between cellular elements and the various compo¬ 
nents of the ground substance, and the manner in which the accumula¬ 
tion of lipid in the vascular wall is mediated, are subjects of active 
research. 
The deleterious effects of surgical transplantation may be so 
severe as to induce FIP in arteries simply resected and reanastamosed 
into their sites of origin (McCann et al., 1979). 
An evaluation of the possible contributing factors towards throm¬ 
bosis in AVGs presents interesting problems. The distinction between 
"red" erythrocyte-fibrin thrombi and "white" platelet-fibrin thrombi 
has been reviewed by Mustard et al. (1962). The former usually arises 
in the setting of stasis, a condition most frequently extant in the 
veins, while the latter appears to arise primarily as a result of 
hemodynamic stress and injury in the arterial system. Relative stasis 
often coincides with hemodynamic stress in AVGs. 
Most of the thrombi which have been described in CABGs appear 
organized and, occasionally, recanalized, making it difficult to 
invoke particular pathogenic mechanisms purely on morphologic grounds. 
Barboriak et al. (1978) demonstrate a fresh thrombus in a CABG which 
consisted primarily of crenated erythrocytes in a fibrin net. Platelet- 
fibrin thrombi have been noted in CABGs inserted in dogs (Brody, 
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Angell and Kosek, 1974). The work of DeWangee et al. (1978) suggest¬ 
ing early platelet compartmentalization in canine CABGs has been 
described above (page 28). 
A more fruitful approach may involve an appreciation of the 
localization of both thrombi and FIP in vein grafts. The frequent 
presence of arterial intimal thickening at branch points, the proximal 
regions of branches, and at bifurcations, is well known. At such 
points, changes in laminar flow patterns (turbulence) and unusually 
severe shear and drag forces tend to prevail (Gessner, 1973; Glagov, 
1973). Such stresses may adversely affect the vessel wall not only 
on the basis of direct endothelial injury but, along with increases 
in wall tension secondary to elevations in blood pressure, may con¬ 
tribute towards changes in endothelial permeability. As a result, 
"insudation" of plasma components may occur (Walton, 1975), particu¬ 
larly LDL and fibrinogen. 
Paradoxically, regions of low shear force in the thickened 
boundary layers prevailing in the outer wall of a branch may lead to 
wall thickening in arteries by permitting, as a result of relative 
stasis in that boundary layer, increased passage of plasma components 
into vessel walls (Caro, Fitz-Gerald and Schrotter, 1969). Restriction 
of thrombosis, FIP and AS to particular regions of specific graft 
segments has not been remarked on. Enhanced venous susceptibility 
to fluid mechanical disturbances may prevent the sparing of one side 
of a vein wall with respect to the other. 
Pathologic changes may occur with greater frequency at particular 
regions along the length of a graft. Of seven thrombi noted by Lie, 
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Lawrie and Morris (1977) in CABGs, four were present in the distal 
and one near the proximal anastamosis. Similarly, Bulkley and 
Hutchins (1978) found that obstructive changes in CABGs are almost 
invariably confined to the juncture of graft and coronary artery. 
Several observers have disagreed as to whether FIP is a segmental 
process. In femoral vein-iliac artery grafts in dogs, Bond et al. 
(1976) did find that FIP predominated near the proximal and distal 
graft anastamoses, and in canine jugular vein-iliac artery grafts, 
FIP was found mostly at the suture sites (Faulkner et al., 1975). 
Other workers have claimed that FIP is a circumferential process 
affecting the length of the vein wall (Roscher and Kern, 1977). One 
cannot rule out that the hemodynamic stress imposed by exposure to 
arterial pressure should affect, to some degree, the entire length 
of a patent graft. FIP may arise initially at branch points and 
sites of suture-induced trauma before extending to the rest of the 
graft. Many more grafts will have to be examined before the evolu¬ 
tion of FIP can be securely delineated. With the data now available, 
it appears that thrombi do arise primarily at or near anastamotic 
sites. 
A particular pattern of atheroma distribution in CABGs has yet 
to emerge. Exceptions include the findings of Ejrup, Hiertonn and 
Moberg (1961) and King and Royle (1972) (see Table 2). 
An "ideal" angle for CABG placement into the aorta has been 
calculated by Kennedy et al. (1974). By matching coronary artery 
impedance to the aortic pressure wave over a cardiac cycle in a 
computer model, ninety degreeswas found to be the angle most likely 
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to prevent the development of significant shear forces within the 
graft. Some support for this finding has been seen in peripheral 
vein grafts in dogs (Bond et al., 1976), with grafts taking off at 
acute angles developing significantly more FIP than those taking off 
at 90 degrees. Grafts taking off at 120 degrees also showed some 
apring, however. No effect of angle variation at the aortic anasta- 
mosis was noted by Breyer et al. (1976) in 13 SV CABGs in dogs. A 
survey of CABG-aortic angles and CABG pathology in post-mortem cases 
has yet to be performed. Once again, however, consideration should 
be given to the likelihood that changes attendant on prolonged graft 
patency might obscure any initial changes which might be observed. 
Factors expected to enhance stasis and, consequently, the contact 
time of circulating molecules (particularly LDL and fibrinogen) and 
formed elements with the vein wall, have been gauged by means of 
intra-operative measurements of graft flow rate and post-operative 
angiographic determinations of distal grafted vessel runoff and 
stenosis. 
Angiography performed 10 to 21 days post-operatively on 70 patients 
(103 grafts) who underwent coronary revascularization showed that all 
grafts with intra-operative flow rates less than 20 milliliters per 
minute, or which failed to respond to papaverine, were closed, while 
all those with flow rates greater than 45 ml/min, or which responded 
to papaverine, were open (Grondin et al., 1971b). Failure to increase 
flow on administration of papaverine suggests distal coronary artery 
stenosis. Fifty per cent of CABGs with intra-operative flow rates 
less than 20 ml/min have been seen to be completely obstructed at three 
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months in another study (Walker et al., 1972), with 90% patency 
achieved with flow rates greater than 41 ml/min. 
In a review of post-operative angiograms performed on 276 femero- 
popliteal SV grafts at Columbia-Presbyterian Medical Center, 57% of 
grafts having three vessel runoff were patent at five years, while all 
grafts with zero vessel runoff were closed (Buda et al., 1976). Koontz 
and Stansel (1972) examined similar data accumulated at Yale-New Haven 
Hospital and concluded that outflow tract runoff was not as critical 
in maintaining graft patency as the diameter of the grafted vein, 
with veins less than five millimeters in diameter especially prone to 
closure. End-arterectomy was also implicated as a risk factor, sug¬ 
gesting that subsequent arterial obstruction could contribute to graft 
closure by promoting stasis. 
CABG patency has been related to the size of the grafted artery, 
with grafts placed on coronary arteries less than 1.5 millimeters in 
diameter practically assuring gv-aft closure (Bourassa et al. , 1972 ; 
Lesperance et al. , 1972). A correlation was also established in these 
studies between poor distal vessel runoff and graft closure. The 
different emphases which have been placed on the sizes of graft and 
grafted vessel suggests that an evaluation of the effects of the ratio 
of the two diameters might provide additional information. 
Furuse et al. (1972) showed that halving of the ratio of graft 
to grafted vessel diameter leads to nearly a doubling of flow rate in 




Laplace's law (tension = pressure x radius) predicts that an 
increase in graft diameter might result in elevated graft wall tension. 
In addition, increases in graft diameter are likely to be directly 
related to increases in intra-graft turbulence, since the Reynolds 
number is a. direct function of vessel diameter. Since the Reynolds 
number is also a direct function of flow rate, consideration should 
be given to the possible deliterious effects of high, as well as low, 
flow rates. 
Grafts in which the flow rates have been highest — SV aorto- 
renal bypass grafts — have not been immune to FIP. Flow rates in 
such grafts exceed those in CABGs by factors of three to four (Stanley 
et al., 1973; Dean et al., 1974). Faulkner et al. (1975) achieved an 
average 6.7 fold increase in flow rate in canine peripheral vein 
grafts by creating distal arteriovenous fistulas. FIP was more marked 
in the high flow grafts as compared to controls, but less than that 
developing in grafts in which stasis had been developed by means of 
distal arterial stenoses. It is possible that high flow rates may 
result not only in enhanced turbulence, but in a "suction" effect 
which might lead to endothelial damage (Texon, Imparato and Lord, 
1960). 
Increases in graft diameter following placement into the arterial 
system are known to occur commonly. Minimalization of post-operative 
graft distension in experimental animals has been achieved by encasing 
grafts in loose mesh prostheses. The effect of this intervention has 
been to markedly decrease the extent of observed FIP in jugular vein- 
common carotid grafts in dogs (Hostetler et al., 1976; Karayannacos 
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et al. , 1978) versus untreated controls. Whether the prevention of 
graft distension or pulsatile flow is of greater import cannot be 
answered by these studies. 
Graft/artery disproportion has been implicated in the etiology 
of graft closure purely on technical grounds. Actual incorporation 
of part of the grafted coronary artery into the anastamosis has been 
claimed to be the principal cause of early graft failure (Bulkley and 
Hutchins, 1977). Large graft/artery diameter ratios (exceeding two) 
was demonstrated to lead to kinking at the anastamotic site by means 
of epoxy resin cast injections of distal CABG anastamoses in isolated 
swine hearts (Young et al., 1978). 
Technical error in angiographically pinpointing sites of coro¬ 
nary artery obstruction, or intraoperative error, was felt to account 
for the observation that 44% of CABGs studied in one series were 
grafted onto coronary arteries which were greater than 75% narrowed 
within two centimeters distal to the anastamosis (Spray and Roberts, 
1977). 
Anoxia constitutes an additional contributing factor towards 
vein graft pathology. Disruptive changes in the adventitia and vasa 
venorum have been described above. While mechanical dilatation or 
adventitial stripping of veins used as femoral artery bypass grafts 
in dogs has been found not to increase the degree of observed FIP 
(Storm et al., 1975), other investigators have come to opposite 
conclusions. 
Canine cephalic and femoral veins used as CABGs have displayed 
fibrotic changes similar to those seen in control veins left in place, 
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but devascularized (Brody, Angell and Kosek, 1972). Autogenous femoral 
veins used as femoral artery bypass grafts in dogs developed FIP 
regardless of whether the vasa were interrupted, but those grafts with 
intact vasa displayed minimal medial pathology (Brody, Kosek and 
Angell, 1972). 
Additional work assessing the role of venous vascularization in 
the pathogenesis of FIP has involved the encasement of grafts in non- 
porous prostheses. FIP has been noted to be especially severe in this 
setting, with the extent of intimal fibrosis correlating inversely 
with the degree of graft revascularization (Hostetler et al., 1976; 
Karayannacos et al. , 1978). 
The extent to which interruption of the vasa venorum contributes 
to the development of atheromatous changes in vein grafts is unclear. 
Dixon (1961) was of the opinion that intact vasa were required to 
prevent intimal anoxia in arteries, and resultant decreases in protein 
synthesis and micellar dispersion of fat. On the other hand, it has 
been claimed that transinitimal passage of oxygen and substrates from 
the vessel lumen is responsible for the nourishment of the arterial 
endothelium (Glagov, 1973). Whether this is true of the veins, or 
whether their increased degree of vascularization is due to an inability 
of the sluggish venous circulation to provide for all the metabolic 
needs of the venous intima, is still not settled. Interestingly, the 
development of atherosclerosis in rabbit arteries has been shown to 
be accompanied by proliferation of intimal arterial vasa which are 
highly permeable and which appear to deposit lipid which becomes en¬ 
gulfed by proliferating, actively phagocytizing intimal cells 
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(Friedman et al., 1962). Long term encasement of venous grafts in non- 
porous prostheses in experimental animals placed on an atherogenic 
regimen might aid in properly weighing the influences exerted by 
devascularization and revascularization in the development of venous 
atheromas. 
An intriguing question is the extent to which veins and arteries 
differ in their susceptibility to atherosclerosis. That veins in 
their native positions are usually resistant to such changes, except 
in the case of the Cramer-Schilling lesion, has been reviewed above. 
Haimovici and Maier (1971) transposed segments of aorta into 
jugular veins in dogs, and placed the animals on an atherogenic 
regimen. Remarkably enough, the aortic grafts developed atheromatous 
changes similar to those found in the native aorta, suggesting that 
the susceptibility of arterial tissue to atherosclerosis is of suf¬ 
ficient magnitude to manifest itself even in a low pressure system. 
Aortic implants into the IVC of rabbits, however, failed to develop 
atherosclerotic lesions comparable to those seen in AVCs, except when 
the aortic grafts had been previously damaged by means of a Magnesium- 
Aluminum thrombogenic spiral (Friedman, 1963). 
Filtration of serum under positive pressure through excised iliac 
arteries and veins (Wilens and McCluskey, 1952) demonstrated that 
both vessels are highly permeable to low molecular weight compounds, 
but the filtration rate is considerably higher in the veins. Retention 
of serum lipids, however, was higher in the arteries. It remains to 
be seen whether the structural alterations which occur in AVGs permit 
greater entrapment of "insuded" lipid over time. While even the most 
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severely fibrosed venous varicosities have been found to be free of 
fat, fibrosis in the face of much higher pressures and pulsatile 
flow may provide conditions which do permit such changes to occur. 
Exposure to systemic pressure may alter lipid metabolism in vein 
grafts. Using carbon-14 labelled acetate to follow the synthesis of 
cholesterol and triglycerides, Larson, Hagen and Fuchs (1974) found 
that explanted canine AVGs incorporated far more counts into all lipid 
classes than control arteries, but only slightly more than control 
veins. While one must be cautious in coming to conclusions on the 
basis of tissue culture experiments, it might be that the inherent 
capacity of the veins for atherogenesis is greater than had been 
realized, particularly under the conditions extant in venous arterial 
conduits. 
Rossiter and co-workers at Stanford University (1974) compared 
the pathologic changes in canine SV and internal mammary artery CABGs. 
Some dogs were placed on atherogenic regimens. Among the dogs on 
regular diets, all SV grafts displayed FIP after three to 15 months, 
with internal mammary artery grafts displaying no such changes. Of 
grafts placed in dogs made hypercholesterolemic, 10 of 12 SV grafts 
and 2 of 6 IMA grafts developed diffuse atherosclerosis. This further 
suggests that veins may be particularly susceptible to the combined 
effects of relative hypertension and hyperlipidemia, with arterial 
injury arising only when hyperlipidemia is combined with the trans¬ 
mural pressure already extant in situ. 
It is possible that the initial suprastructure for the athero¬ 
sclerotic plaque in both veins and arteries consists of platelet-fibrin 
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mural thrombi which, when organized over time, assume the morphologic 
characteristics of true atheromas. Evidence for this possibility 
has taken a great deal of time to develop, ever since Von Rokitansky 
proposed this hypothesis in 1852. 
A beautiful series of photomicrographs published by Duguid (1946, 
1949) of serial sections taken through atherosclerotic coronary ar¬ 
teries and aortas revealed the almost imperceptible manner in which 
typical atherosclerotic plaques blended into regions containing organized 
thrombi. Immunofluorescent localization of fibrin deep within atheromas 
has been reported by Woolfe (1961). More superficial and diffuse 
fibrin deposits in early atherosclerotic plaques, on the other hand, 
may be due to post-mortem insudation of fibrin (Florey, 1960). 
In a similar manner, it may be that FIP is the morphologic equi¬ 
valent of organized deposits of fibrin (Bulkley and Hutchins, 1977 
and 1978; Lie et al., 1977). Such a mechanism for intimal thickening 
in vein grafts has been distinguished from the reactive intimal fibro¬ 
elastosis seen in the intima of veins subjected to the less elevated 
pressures caused by left sided CHF, as has been previously discussed. 
Clinical risk factors for the development of vein graft athero¬ 
sclerosis have not been established, with the exception of hyperlipid¬ 
emia and,particularly, hypertriglyceridemia in CABGs (see Table 2). 
Only anecdotal reports are extant linking AVG atherosclerosis with 
cigarette smoking, hypertension and diabetes mellitus. Further 
clarification of the contributions made by risk factors important in 
the etiology of ASCVD to vein graft atherosclerosis should be forth¬ 
coming. Patients with CABGs are not likely to be afflicted with 
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untreated hypertension, however. In addition, the relative increase 
in blood pressure between normo and hypertensive patients is obviously 
minimal compared to the magnitude of the pressure rise involved in 
transplantation from the native venous system. 
What emerges from the pathologic study of AVGs is that simple, 
all-encompassing explanations are as inadequate in understanding the 
observed findings as they are in connection with arterial disease. 
Response to anoxic or mechanical injury, transudation from the circu¬ 
lation, organization of thrombi are not mutually exclusive events. 
They all may be valid ways of approaching the structural changes which 
have been observed in the venous wall. Each may initiate or temper 
the development of venous pathology. Further study of AVGs should 
help clarify the extent to which FIP is a necessary precursor of the 
atheromatous plaque, and the importance of individual pathogenic 
factors in the development of each lesion. 
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TABLE 3: FACTORS CONTRIBUTING TOWARDS INTIMAL THICKENING IN AVGs 
I. Stasis 
1. Increased graft diameter 
2. Distal or proximal arterial obstruction 
3. Poor distal arterial runoff 
4. Surgically induced narrowing at anastamotic sites 
II. Direct Endothelial Injury 
1. Increased wall tension in presence of arterial pressure 
2. Mechanical dilatation 
3. Interruption of the vasa venorum 
4. Effects of suturing 
5. Effects of medium used to preserve veins before implant 
6. ? effects of white blood cells 
III. Turbulence and Shear/Drag Forces 
1. Angle of graft placement 
2. Narrowing at anastamotic sites 
3. Increased velocity of graft flow (decreased graft diameter) 
IV. Hyperlipidemia 
Direct stimulus for SMC proliferation 
V. Thrombosis 
1. Secondary effect of direct endothelial injury and stasis which 
may increase stasis and turbulence, and act as direct stimulus 
for SMC proliferation 
2. ? ultimate organization as morphologic equivalent of fibrous 
plaques 
VI. Transudation 
? changes in endothelial permeability and their significance 
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SECTION II: IMMUNOFLUORESCENT CHARACTERIZATION OF COLLAGEN TYPES I 
AND III IN NORMAL SAPHENOUS VEINS AND AORTOCORONARY SAPHENOUS VEIN 
GRAFTS 
Collagen represents one of the largest components, by weight, 
of most connective tissues, particularly that of skin, bone, blood 
vessels, tendon and cartilage. Twenty per cent of the dry weight of 
lung may be attributable to collagen, and up to 70% of that of human 
skin. This protein has multiple functions, including the provision 
of tensile strength to tissues, as well as shape, flexibility and 
form; and the establishment of anatomic, and possibly functional, 
boundaries among cells and tissues (Gross, 1974). 
The biosynthesis, structure and metabolism of collagen have been 
intensively studied. Excellent brief (Miller and Matukas, 1974; Uitto 
and Lichtenstein, 1976) and comprehensive (Bornstein, 1974) surveys 
of collagen biosynthesis have been published. Collagen degradative 
pathways have been reviewed by Perez-Tamayo (1978). 
The collagen molecule is composed of a triple helical arrangement 
of three polypeptide chains, each approximately containing 1000 amino 
acids (95,000 daltons). The coiled triple helical structure has an 
axial distance of 2.9 $ between amino acid residues, rather than the 
1.5 X seen in the alpha helix. The dimensions of the molecule are 
about 15 8. by 3000 R. 
When organized as fibers, the arrangement of the collagen mole¬ 
cules has been seen to vary under electron microscopy with the method 
of preparation of the examined materials. "Native" fibers appear to 
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have repeating axial periods of 640 ft, or one quarter the length of 
a collagen molecule. These fibers consist of collagen molecules 
arranged in parallel register, but staggered by one quarter of their 
lengths. Different periodicities, representing variations in the 
dispositions of individual collagen molecules in whole fibers, are 
seen when collagen is extracted with citrate buffer and dialysed 
against water (Fibrous Long Spacing - FLS - arrangement), or treated 
with Adenosine Triphosphate in acid solution (Segment Long Spacing - 
SLS - arrangement). 
The synthesis of the collagen triple helix involves a concerted 
series of intra and extracellular steps, with post-translational 
modification of individual amino acid residues playing prominent roles 
in the generation of the final structure. 
Repeating amino acid residue triads of the general form X-Y-gly 
are characteristic of the collagen molecule, and appear essential to 
the maintenance of the molecule's stability. The first residue of 
this triad is usually proline, followed by either hydroxypro line or 
hydroxylysine. 
The initial product of ribosomal translation of a collagen chain 
messenger RNA is a molecule of higher molecular weight than that of 
the native collagen molecule. These precursor chains are usually 200 
to 300 amino acids longer than the final product at the carboxy ter¬ 
minus, and about 100 amino acids longer at the amino terminus. These 
extension peptides tend to be richer in acidic amino acids, and poorer 




Hydroxylation of proline and lysine residues begins while the 
precursor, or procollagen, chains are being assembled on ribosomes. 
Lysine and proline hydroxylases, specific for lysine and proline 
residues in the Y position, operate in conjunction with Iron (II), 
alpha ketoglutarate and ascorbic acid as cofactors. 
An additional non-mRNA template directed synthetic step involves 
glycosylation of newly hydroxylated lysine residues. An O-glycosidic 
linkage is formed between the 3-hydroxy group of hydroxylysine, and 
galactose. Glucose may then be added to the galactosyl moiety. Spe¬ 
cific galactosyl and glucosyl transferases are utilized in this step, 
with Uridine Diphosphate-Sugar as the carbohydrate source, and Manga¬ 
nese (II) as cofactor. 
The three precursor chains associate into a triple helix, a 
process most likely facilitated by relatively specific interactions 
between the terminal extension peptides. These interactions are not 
purely non-covalent. The rate of formation of interchain disulfide 
bonds between half-cysteine residues in the extension peptides is 
proportional to the rate of formation of the triple helical product, 
pro collagen. 
Procollagen is secreted into the extracellular space, where endo- 
peptidases capable of removing the amino and carboxy terminus exten¬ 
sion peptides operate. These procollagen peptidases permit the 
spontaneous formation of insoluble collagen molecules and fibers from 
the soluble procollagen molecule. 
Additional stability and tensile strength is afforded the newly 
formed collagen molecule by specific cross-links. The epsilon amino 
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groups of some lysine and hydroxy lysine residues are first converted 
into aldehyde groups. This oxidative deamination is mediated by 
lysyl oxidase, an enzyme which is Copper (II) dependent. These ter¬ 
minal aldehyde groups may then form stable Schiff bases with the 
unaltered epsilon amino groups of other lysine or hydroxylysine resi¬ 
dues, a cross-link most often associated with interchain interactions; 
or two aldehyde groups may form a bond through an aldol condensation, 
a common form of intramolecular linkage. The steps involved in col¬ 
lagen biosynthesis are schematized in Figure 1. 
Collagen degradation is effected by cleavage of a single, specific 
peptide bond along the collagen helix recognized by specific colla- 
genases. Collagenases have been isolated in numerous species, including 
crabs and flatworms, and in a large number of human connective tissues, 
as well as human platelets, granulocytes and macrophages. 
Mechanisms controlling collagen synthesis and degradation are 
not well understood. Collagen biosynthesis has been associated with 
formation of polyribosomal aggregates, the activity of prolyl hydroxy¬ 
lase, the size of the intracellular proline pool, and the possible 
negative feedback effects of free terminal extension peptides. Collagen 
degradation may be related to the degree of cross-linking in each 
molecule, with highly cross-linked molecules being particularly stable. 
The nature of the molecular interactions involved in the stimulation 
and repression of collagen synthesis and breakdown remain unknown. 
Increasing attention is being directed towards the elucidation 
of different collagen types. The structural and functional individu¬ 
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Figure 1. Schematic representation of collagen biosynthesis. 
From Uitto and Lichtenstein (1976). 
distinct collagen polypeptide chains. The nomenclature and locali¬ 
zation of collagen type I, II, III, and IV is summarized in Table 4. 




TABLE 4: HUMAN COLLAGEN TYPES 
-7L'7d77 vc amino acid compositions 
Chain 
Type composition Cham ■ilhp 3-llvp //,/ Gly V; Cys Predominant tissue distribution 




 0.8 9.2 347 0 be.irt vjIvc, fascia, sc.ir, cornea, 
liver, dentin i t-'s-sus. 
II ol (II) 97 2 14 326 0 Cartilage, nucleus pulposus, notochord 
III al (III) 124 0 5 354 2 Cardiov ascular tissue, lung, liver, denies. 
intestine, leiomyoma 
IV [al(IV)]3 all IV) 130 11 45 310 8 Basement membranes 
Amino acid composition is expressed in residues/1000 amino 
acid residues. Values for type I and III collagen are from 
human dermis, type II is from human articular cartilage, 
and type IV from human glomerular basement membrane. 
Modified from Pinnell (1978). 
The structure of type I, II and III collagen is relatively well 
understood. Methods of isolation, purification and characterization 
of these collagens may be found in the references cited in Table 5. 
The structure of type IV collagen is more controversial, and may 
actually be similar to that of procollagen (Orkin et al., 1977). 
TABLE 5: ISOLATION AND CHARACTERIZATION OF TYPE I, II AND III 
COLLAGEN - SOURCES 
Type I Collagen 
Piez, Eigner and Lewis (1963) 
Rauterberg and Kuhn (1971) 
Type II Collagen 
Miller and Matukas (1969) 
Miller and Lunde (1973) 
Type III Collagen 
Chung and Miller (1974) 
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A fifth collagen type has been isolated from human placentas. 
This protein appears to be composed of two distinct collage polypep¬ 
tide chains, call aA and aB (Burgeson et al., 1976). The stoichio¬ 
metry of the type V collagen triple helix has not been conclusively 
demonstrated. A recent indirect immunofluores cent study showed that 
type V collagen is found throughout normal human lung, but primarily 
in association with basement membranes (Madri and Furthmayr, 1979a). 
Antibodies raised to this collagen were shown not to cross react with 
the previously demonstrated basement membrane collagen, type IV. 
An additional collagenous protein has been isolated from Rhesus 
monkey SMC cultures (Mayne, Vail and Miller, 1978). Called CP45, it 
has a molecular weight of 45,000 daltons, and its structure and 
function remain to be determined. 
Not surprisingly, several disease states have been linked to 
specific defects in collagen biosynthesis. These disorders, ranging 
from acquired deficiency states to inborn errors of metabolism, have 
been reviewed by Uitto and Lichtenstein (1976) and Pinnell (1978). 
In the work described below, indirect immunofluores cent micro¬ 
scopy using specific anti-type I and anti-type III antibodies were 
used to evaluate the presence of these collagens in saphenous vein 
aortocoronary bypass grafts and ungrafted saphenous veins. As will 
be discussed, alterations in collagen type, in addition to absolute 
increments or deficits in collagen biosynthesis and degradation, may 
be of pathological significance. 
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MATERIAL AND METHODS 
1. Primary and Secondary Antibodies 
Antibodies to type I and type III collagen were provided by 
Dr. Joseph Madri, Department of Pathology, Yale University School of 
Medicine. 
Acid soluble type I collagen was prepared from calf skin and 
pepsin soluble type III collagen from human placental membranes ac¬ 
cording to the method of Burgeson et al. (1976). 
Antibodies to type I and type III collagen were raised in rabbits 
and purified by immunoadsorbtion on affinity columns containing spe¬ 
cific antigen (Nowack et al., 1976). The specificity of the antibodies 
was enhanced by cross-adsorbtion on affinity columns in which the 
cyanogen bromide activated Sepharose IV beads were linked to the other 
collagen types (Table 6). The titer of the primary antibodies was 1 
to 100,000 by hemagglutination-inhibition (Figure 2). 
The secondary antibody used was fluorescein-isothiocyanate 
conjugated sheep anti-rabbit IgG fraction (Hyland Laboratories). 
Primary and secondary antibodies were stored at -60° C, and 
diluted 1 to 1000 and 1 to 20, respectively, with phosphate buffered 
saline (PBS) prior to use. 
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TABLE 6: COLLAGEN TYPES USED IN AFFINITY COLUMNS FOR PURIFICATION 
OF TYPE-SPECIFIC ANTI-COLLAGEN ANTIBODIES* 
Affinity Columns for Affinity Columns for 
Sera Cross-adsorptions Immunoadsorption 
Anti type I II , III , iv , V I 
Anti type II I, III, IV, V II 
Anti type III I, II, IV, V III 
Anti type IV I, II, III, V IV 
Anti type V I, II, III, IV V 











i || iii iv v iii ill iv v i ii iii rv v i ii hi iv v i ii in iv \ 
Anti- I Anti - Anti - Anti - IV Anti - V 
Figure 2. Hemagglutination-inhibition study of the specificity 
of collagen antibodies. Initial dilution of antibodies was 
1:100. Concentration of collagens used as inhibitors was 2.5 
micrograms. From Madri and Furthmayr (1979b). 
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2. Saphenous Veins 
Thirteen saphenous veins were obtained from twelve patients 
undergoing initial coronary artery bypass surgery at Yale-New Haven 
Hospital, and from one patient undergoing a second revascularization 
procedure at the West Haven Veterans Administration Hospital. These 
patients represent a non-consecutive series of cases between September 30 
and December 31, 1978. Characteristics of this group of patients are 
summarized in Table 7. 
Six coronary artery bypass grafts were obtained from two patients 
undergoing a second CABG at Yale-New Haven Hospital (two grafts from 
each patient), and one patient having a second CABG at Yale-New Haven 
Hospital. Although one patient in this group received an internal 
mammary artery graft, the six grafts obtained were SV grafts. Clinical 
features of the three patients are summarized in Table 8. 
All ungrafted veins were mechanically dilated with heparinized 
saline by the surgical team. The dilated vein was then measured and 
residual vein, usually about one to two centimeters, was provided for 
this work. Both ungrafted veins and excised bypass grafts were cut 
into multiple transverse sections, placed in a petri dish containing 
O.C.T. embedding medium (Lab-Tek), frozen in liquid nitrogen, and 
stored at -60° C. 
3. Staining Procedure 
Slides were prepared by washing in 1% hydrochloric acid-absolute 
ethanol, drying with lint-free paper, coating with chicken egg albumin 
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TABLE 7: UNGRAFTED SAPHENOUS VEINS - PATIENT CHARACTERISTICS 
Number of veins 13 
Number of patients 13 
Male 11 
Female 2 
Average age 60.2 years (46.8 to 78.0 years) 
Male 57.9 years (46.8 to 72.2 years) 
Female 72.4 years (66.7 and 78.0 years) 
Histories of venous varicosities and/or evidence of venous stasis 
disease on physical examination were recorded in only one patient, a 
47 year old male. 
o 
to prevent loss of tissue, and baking overnight at 60 C. 
Six micron frozen sections were cut from the 0.C.T.-embedded veins 
on a cryostat. Multiple hematoxylin and cosin sections were prepared 
in order to assess the preservation of tissue architecture. Tissue 
deemed acceptable was then cut, with two sections placed on each slide. 
The slides were stored overnight at 4° C. 
The staining method is based on one that has been in routine use 
for immunofluorescent studies of kidney biopsy frozen sections at 
Yale-New Haven Hospital. Methods of this kind have been described in 
detail by Goldman (1968) and do not, in principle, differ essentially 
from the first accounts of indirect immunofluorescent methods (Weller 
and Coons, 1954; Mellors, Arias-Stella, et al., 1955). The technique 
as a whole derives from the work of Coons and co-workers (1942) , who 
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TABLE 8: BYPASS GRAFTS - CLINICAL FEATURES 




Sex M M F 
Initial Surgery SV to RCA and 
L-CIRC 
SV to RCA and 
L-CIRC; IMA 
to LAD 
SV to RCA and 
L-CIRC 























grade IMA lesion 
RCA and L-CIRC 
grafts occluded 
* A segment of SV prepared for use as a repeat graft was obtained 
from this patient, and is included in the total in Table 8. 
AODM - adult onset diabetes mellitus; FH - positive family history 
for ASCVD; LAD - left anterior descending artery; L-CIRC - left 
circumflex artery; RCA - right coronary artery; IMA - internal 
mammary artery. 
described the use of impure fluorescein-isocyanate conjugated anti¬ 
bodies to type 3 pneumococcus to demonstrate the presence of that 
organism in infected mice. This direct method has largely given way 
to the convenience and flexibility afforded by the indirect technique. 
Sections and staining materials were allowed to reach room 
temperature. Slides were fixed for ten minutes in acetone, and re¬ 
hydrated for three minutes in PBS. 
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Primary antibody was applied for sixty minutes, and slides were 
washed for a total of nine minutes in three changes of PBS. Secondary 
antibody was then applied for forty minutes, and the slides washed as 
above. All staining was done in a covered moist box to prevent tissue 
dessication. The stained slides were then mounted with polyvinyl 
alcohol-glycerin and stored at 4° C for one hour, after which they 
were ready for photomicrography. 
4. Photomicrography 
A Zeiss fluorescence microscope and camera were used, with a 
vertical illuminator using a super pressure mercury arc lamp as the 
light source. A Zeiss barrier filter was utilized which permitted 
the passage of excitation wavelengths ranging from 450 to 490 nanometers, 
and transmitted wavelengths greater than 520 nanometers. The excita¬ 
tion wavelength is ideal for work with fluorescein conjugates, as the 
absorption spectrum of fluorescein begins to rise at 420 nanometers 
and is maximal between 485 and 495 nanometers (Goldman, 1968). The 
transmitted spectrum permits easy recognition of fluorescein’s sharp 
green fluorescence, as well as the yellow autofluorescence character¬ 
istic of elastic tissue (Hicks and Matthaei, 1955). 
The extent of fluorescein fluorescence was assessed on an arbi¬ 
trary 0 to 4+ scale for each section stained with anti-type I and 
anti-type III collagen antibodies. 
Photomicrographs were obtained of all stained veins. Sections 
at 250X magnification were photographed with Kodak ASA 400 Ektachrome 
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film for slides, and developed at 400. Exposures were arbitrarily 




A summary of the fluorescence noted in each specimen is presented 
in Table 9. 
No remarkable pattern of distribution of fluorescence in the 
venous wall for each collagen type was noted. In general, specimens 
graded 3+ to 4+ displayed a diffuse, homogeneous fluorescence through¬ 
out the vein wall. Specimens graded 1+ and 2+ tended to have their 
fluorescence concentrated at the abluminal side of the vein wall. 
Absence of type III collagen, as gauged by absence of specific 
fluorescence, was not observed in all 13 ungrafted saphenous veins, 
and the six bypass grafts. Type I collagen was not present in 4 of 
the 13 normal veins (30%) and 2 of 5 grafts (40%). 
When both type I and type III collagen were present, fluorescence 
attributable to staining of type III collagen exceeded that due to 
type I collagen in 8 of 9 ungrafted veins (89%) and 3 of 3 grafts. 
Maximal (4+) fluorescence was seen only in normal veins, 5 of 13 
(38%) of which displayed 4+ fluorescence with respect to type III 
collagen. 
The two grafts which had 2+ fluorescence with respect to type I 
collagen were angiographically demonstrated to be occluded, while the 
two grafts which failed to stain positively for type I collagen were 
shown to be patent at angiography (see Table 8). 
Yellow autofluorescence suggestive of elastic tissue was not 
prominent in any section and when present took the form of wavy 
streaks diffusely distributed throughout the vein. A well developed 
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TABLE 9: FLUORESCENCE IN STAINED SPECIMENS 
Ungrafted Veins 
Age of Patient Sex Type I Collagen Type III Collagen 
57.0 M 1+ 3+ 
63.0 M 3+ 4+ 
1 
58.0 M 0 4+ 
66.7 F 3+ 3+ 
59.0 M 0 2+ 
54.3 M 1+ 4+ 
47.12 M 1+ 3+ 
58.8 M 3+ 3+ 
61.0 M 0 3+ 
60.4 M 1+ 2+ 
78.0 F 1+ 4+ 
72.2 M 1+ 4+ 
46.8 M 0 3+ 
\his patient's original bypass grafts were obtained during a second 
bypass procedure (case number 2). 
2 
Superficial varicosities were noted in this patient. 
Coronary Artery Bypass Grafts 
Type I Collagen Type III Collagen 
Case 1 
Graft to RCA 2+ 39- 
Graft to L-CIRC 0 3+ 
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TABLE 9 (Cont’d) 
Type I Collagen Type III Collagen 
Case 2 
Graft to RCA 0 3+ 
Graft to L-CIRC 2+ 3+ 
Case 3 
Graft to RCA - 2+ 
Graft to L-CIRC 1+ 3+ 
internal or external elastic lamina was not seen in any section. 
Dull green autofluorescence was seen at the cut edge of sections. 
This fluorescence might have been enhanced by the frozen section 
method of tissue processing. 
The appropriate statistical test of significance for these data, 
Chi-square with one degree of freedom, was not applied because the 
small sample size precludes meaningful application of this method. 
Examples of prominent type III and weak type I fluorescence in 
an ungrafted vein are presented in Figures 3 and 4. Type III pre¬ 
dominance is also shown in the graft to the right coronary artery 
from case 2 (Figures 5 and 6), and appreciable fluorescence attribu¬ 
table to both collagen types are demonstrated in the graft to the left 
circumflex coronary artery of the same patient (Figures 7 and 8). 


Figure 3. Ungrafted saphenous vein from a 57 year old man. Type I 
collagen. Lumen is below. Non-specific fluorescence is 
evident in wavy fragments scattered throughout the vein 
wall. This might represent elastin. 250X. 
Figure 4. Same vein as in Figure 3. Type III collagen. Poor preser¬ 







Saphenous vein bypass graft to right coronary artery 
(case 2). Type I collagen. Tissue is folded at luminal 
edge. 250X. 
Same vein graft as in Figure 5. Type III collagen. Luir. 






Saphenous vein bypass graft to left circumflex coronary 
artery (case 2). Type I collagen. Lumen is to the right. 
250X. 






The relative quantities of type I and type III collagen in 
grafted saphenous veins demonstrated in this study do not permit the 
drawing of firm conclusions. It appears that type III collagen pre¬ 
dominates in both ungrafted and grafted veins, with possibly more 
type III collagen in ungrafted veins. Remarkable differences in flu¬ 
orescence due to type I collagen were not apparent. 
A major difficulty of this analysis, aside from the limitations 
imposed by its qualitative nature, is the fact that only one of the 
six studied vein grafts was demonstrated to be widely patent at pre¬ 
operative coronary angiography. The precise length of time for which 
the grafts were actually exposed to increases in transmural pressure 
cannot be determined. Observed changes might have differed if sections 
of graft were obtained proximal and distal to an obstruction. In 
addition, changes in collagen type might have been accentuated had 
normal veins been obtained from younger patients. The effects of 
age on collagen type in the vascular system have not been established. 
Alterations in the ratio of type I to type III collagen has been 
demonstrated in human atherosclerotic plaques. By means of cyanogen 
bromide peptide analysis, McCullagh and Ballian (1975) found that 
normal human aortas contain 70% type III collagen and 30% type I 
collagen, while atherosclerotic aortas contain an average of 35% type 
III and 65% type I collagen. 
This change in the preponderant collagen type introduces an impor¬ 
tant additional dimension to the knowledge which has accumulated in 
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experimental animals regarding overall alterations in collagen meta¬ 
bolism in atherosclerosis (Langner and Modrak, 1976; McCullagh and 
Erhart, 1974 and 1977) and hypertension (Spector et al., 1978). These 
studies have complemented the body of morphologic evidence reviewed 
above regarding the development of fibrosis in the vascular wall in 
those disease states. Increased collagen biosynthesis and/or turn¬ 
over in the arterial wall accompany both hypertension and atheroscler¬ 
osis. Whether such changes are accelerated in venous grafts has not 
been determined, but appears likely on morphologic grounds. 
Changes in collagen type have been demonstrated in other disease 
states. A decrease in type III collagen (31% to 12-24%), with a 
relative increase in type I collagen, has been seen in lungs from 
patients with idiopathic pulmonary fibrosis as compared with controls 
(Seyer, Hutcheson and Kang, 1976). In this study, lung from a patient 
with pulmonary fibrosis and scleroderma, a condition in which a pro- 
pagable increase in collagen biosynthesis by dermal fibroblasts has 
been demonstrated (Buckingham et al., 1978), did not display an altera¬ 
tion in collagen type. 
Similarly, a decrease in type III collagen (47% to 18-34%) with 
a proportionate increase in type I collagen has been found in livers 
of patients with Laennec's cirrhosis, as compared with controls 
(Seyer, Hutcheson and Kang, 1977). Previous work by Rojkind and Mar- 
tinez-Palomo (1976) indicating that normal liver contains 80% type I 
collagen while livers with Laennec’s cirrhosis have increased quantities 
of both type I and III collagen, with both present in equal propor¬ 
tions, may have been affected by cross-contamination during the 
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isolation of the individual collagen types. 
It is tempting to speculate that alterations in the ratio of 
type I to type III collagen, with possible increases in type I and 
decreases in type III collagen, might be characteristic of fibrotic 
processes in diverse settings. The perturbations which might affect 
specific collagen type biosynthetic and degradative pathways remain 
to be determined. The functional significance of alterations in col¬ 
lagen type are also unknown. 
One indication of type III collagen's function in the vascular 
wall emerges from an immunofluorescent microscopic study of human 
arteries (Gay et al., 1975). Type III collagen was shown to be dif¬ 
fusely present throughout the arterial wall, but was primarily 
localized in the subendothelium. Type I collagen was less prominent 
in the abluminal side of the vessel wall, but was seen to be increased 
towards the adventitia. The predominance of type III collagen in the 
subendothelium suggested that this collagen type might be especially 
effective in the induction of platelet aggregation and thrombosis. 
Which collagen type is most effective as a platelet aggregator 
is controversial. Acid solubilized human and chick type III collagen 
has been found to be more potent in causing platelet aggregation than 
type I collagen. This difference was reduced substantially when the 
collagens were treated with Na^HPO^ to induce fibrillogenesis — an 
important finding, since native collagen is present in fibrillar form 
in the tissues (Barnes, Gordon and MacIntyre, 1976). Baillesen et al. 
(1975) found that fibrillar bovine type III collagen is a more power¬ 
ful inducer of platelet aggregation than a similar preparation of 
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type I collagen. More recent work has indicated that the actual 
three dimensional configurations of the collagens is of greater con¬ 
sequence in determining platelet aggregation than individual dif¬ 
ferences in amino acid sequence among the collagen chains (Gordon, 
1979). The future use of platelet collagen receptors, such as the 
fibronectin glycoproteins, as molecular probes may help to further 
clarify the nature of platelet-collagen interactions (Bensusan et al., 
1978). 
While evidence for polarity in the distribution of type I and 
III collagen in ungrafted and grafted saphenous veins was not obtained 
in this study, future work might delineate such changes, and relate 
them to the observed propensities of early and late grafts to become 
thrombosed. 
An additional indication of the possible function of type III 
collagen in the vascular wall comes from an investigation of the 
molecular basis of the Ehlers-Danlos Syndrome, Type IV. Joint hyper¬ 
extensibility is not as prominent in this disorder as in the other 
types making up the spectrum of the Ehlers-Danlos Syndrome. Rather, 
easy bruisability and death secondary to arterial rupture and gastro¬ 
intestinal perforation are frequent findings (Pinnell, 1978). Patients 
with this disease have been shown to have marked reductions in aortic 
type III collagen, and their skin fibroblasts appear capable solely 
of synthesizing type I collagen (Pope et al., 1975). 
Changes in the composition of the collagens occur in fibrotic 
processes in parenchymal organs and in atherosclerosis. Type III 
collagen may be of prime importance in the maintenance of overall 
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structural integrity in the vascular wall. Collagen type and dis¬ 
tribution may affect a blood vessel's susceptibility towards thrombosis. 
At this juncture, very little can be concluded about the pathological 
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